Literature DB >> 18648614

The temporal hormesis of drug therapies.

Noor Dudekula1, Vikas Arora, Zsuzsanna Callaerts-Vegh, Richard A Bond.   

Abstract

Recent publications in the field of asthma therapeutics and studies performed over the last decade in the treatment of chronic heart failure suggest a phenomenon called 'temporal hormesis'. This phenomenon can be defined as the beneficial action of drug after chronic administration as opposed to its detrimental acute effects. Temporal hormesis may be related to the classification of the drug molecule as an agonist, antagonist or an inverse agonist. This phenomenon may be a more general principal applicable in the treatment of other diseases apart from asthma and chronic heart failure.

Entities:  

Keywords:  Asthma; Beta-adrenoceptor antagonist; Chronic therapy; Heart failure; Temporal hormesis

Year:  2006        PMID: 18648614      PMCID: PMC2475944          DOI: 10.2203/dose-response.003.03.009

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  44 in total

1.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

Authors:  P Lechat; M Packer; S Chalon; M Cucherat; T Arab; J P Boissel
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

3.  Regulation of beta 1- and beta 2-adrenoceptors following chronic treatment with beta-adrenoceptor antagonists.

Authors:  M S Elfellah; J L Reid
Journal:  Eur J Pharmacol       Date:  1989-11-28       Impact factor: 4.432

4.  Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium.

Authors:  C Maack; S Tyroller; P Schnabel; B Cremers; E Dabew; M Südkamp; M Böhm
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.

Authors:  P Samama; G Pei; T Costa; S Cotecchia; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

6.  Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.

Authors:  M L Kukin; R S Freudenberger; M M Mannino; J Kalman; M Steinmetz; C Buchholz-Varley; O N Ocampo
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

7.  Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

Authors: 
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

8.  Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of beta 2-selective sympathomimetics.

Authors:  L Mazzoni; R Naef; I D Chapman; J Morley
Journal:  Pulm Pharmacol       Date:  1994-12

9.  Airway mucosal thickening and bronchial hyperresponsiveness induced by inhaled beta 2-agonist in mice.

Authors:  Jun Tamaoki; Etsuko Tagaya; Kiyomi Kawatani; Junko Nakata; Yumie Endo; Atsushi Nagai
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

10.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

View more
  4 in total

1.  Hormesis pervasiveness and its potential implications for pharmaceutical research and development.

Authors:  Kenneth I Maynard
Journal:  Dose Response       Date:  2011-07-29       Impact factor: 2.658

2.  Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling.

Authors:  Erica S Lovelace; Jessica Wagoner; James MacDonald; Theo Bammler; Jacob Bruckner; Jessica Brownell; Richard P Beyer; Erika M Zink; Young-Mo Kim; Jennifer E Kyle; Bobbie-Jo M Webb-Robertson; Katrina M Waters; Thomas O Metz; Federico Farin; Nicholas H Oberlies; Stephen J Polyak
Journal:  J Nat Prod       Date:  2015-07-17       Impact factor: 4.050

Review 3.  Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.

Authors:  Nicola A Hanania; Burton F Dickey; Richard A Bond
Journal:  Curr Opin Pulm Med       Date:  2010-01       Impact factor: 3.155

4.  NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.

Authors:  Christopher M Hine; James R Mitchell
Journal:  J Clin Exp Pathol       Date:  2012-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.